Heather Denroche

Company: Integrated Nanotherapeutics

Job title: Director - Preclinical Development

Seminars:

Developing LNP/mRNA Therapeutics to Achieve Antigen-Specific Immune Tolerance 8:30 am

• Highlighting the unique benefits of using a Multi-Cargo LNP approach to deliver autoantigens and modulate the immune system • Discussing the biodistribution and mechanism of LNP/mRNA in inducing immune tolerance • Showcasing the therapeutic potential of LNP/mRNA technology in type 1 diabetes and other autoimmune diseasesRead more

day: Custom Day Two

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.